Work

Investigator-sponsored trial of efficacy and tolerability of cabozantinib (cabo) at lower dose: A dose-finding study in men with castration-resistant prostate cancer (CRPC) and bone metastases.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4566

Authors: Richard J. Lee, M. Dror Michaelson, Philip James Saylor, Carol Ann Gurski, Stephen M. Rothenberg, David Tomoaki Miyamoto, Shyamala Maheswaran, Daniel A. Haber, Jonathan G. Goldin, Matthew Raymond Smith

Institutions: Massachusetts General Hospital, University of California, Los Angeles

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2966624951

Cites:

Cited by: 2

Related to: 10